Stocks Industrials MLAB
NASDAQ · IndustrialsMesa Laboratories Inc (MLAB)
Mesa Laboratories Inc brought in $251.3M of revenue over the twelve months to September 30, 2026, up 2.5% from a year earlier. Net income was $6.7M, a net margin of 2.7%. Operating cash flow minus capital spending left $39.6M of free cash flow in fiscal 2026. At September 30, 2026 it held $22.3M in cash against $64.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 9, 2026.
Key facts about Mesa Laboratories Inc
- Net worth
- Mesa Laboratories Inc has a market value (market cap) of $715.3M at the latest share price, and shareholders' equity of $194.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $249.1M (+3.4% year on year), with net income of $6.7M. Over the 12 months to September 30, 2026: revenue $251.3M, net income $6.7M.
- Cash flow
- In fiscal 2026 operations brought in $42.8M of cash; after $3.3M of capital spending, free cash flow was $39.6M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 9, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Mesa Laboratories Inc's next report is expected around February 2, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Mesa Laboratories Inc paid dividends of $0.64 per share in fiscal 2026, a yield of 0.50% at the current price.
What Mesa Laboratories Inc does
Mesa Laboratories Inc is registered with the SEC under industry code SIC 3823 (Industrial Instruments For Measurement, Display, and Control). Its shares trade on NASDAQ under the ticker MLAB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $249.1M | $6.7M | $1.21 | $39.6M |
| 2025 | $241M | -$2M | -$0.36 | $42.6M |
| 2024 | $216.2M | -$254.2M | -$47.20 | $41.6M |
| 2023 | $219.1M | $930K | $0.17 | $23.4M |
| 2022 | $184.3M | $1.9M | $0.35 | $34.8M |
| 2021 | $133.9M | $3.3M | $0.64 | $35.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MLAB ranks in Industrials
Dividends
Mesa Laboratories Inc paid $0.64 per share in fiscal 2026. At the current price that is a yield of 0.50%. It paid out $3.5M in cash dividends, 52% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2026 | $0.64 | $3.5M | 52% |
| 2025 | $0.64 | $3.5M | n/a |
| 2024 | $0.64 | $3.4M | n/a |
| 2023 | $0.64 | $3.4M | 366% |
| 2022 | $0.64 | $3.3M | 178% |
| 2021 | $0.64 | $3.2M | 97% |
Latest SEC filings
What Mesa Laboratories Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026
- November 9, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 2.6% to $62.3M versus the same quarter last year; diluted EPS $0.75 versus $0.45.
- October 27, 2026Passive stake changed SCHEDULE 13G/A
- October 13, 2026
- October 9, 2026Passive stake (5% or more) SCHEDULE 13G
- September 8, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 1% to $60.1M versus the same quarter last year; diluted EPS $0.49 versus $0.85.
- August 10, 2026
- July 30, 2026
- July 22, 2026Proxy statement DEF 14A
What is MLAB worth? A DCF from its reported cash flow
Insider trades
What the people running Mesa Laboratories Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $902.4K and sold $800.1K worth of shares in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 13, 2026 | Sullivan John JamesDirector | Gave as a gift | 1,200 | - |
| August 15, 2026 | Sullivan John JamesDirector | Exercised options | 2,784 | - |
| August 15, 2026 | Tripeny R TonyDirector | Exercised options | 2,784 | - |
| August 15, 2026 | Hall ShannonDirector | Exercised options | 2,784 | - |
| August 15, 2026 | Ladiwala Shiraz ShabanaliDirector | Exercised options | 3,810 | - |
| August 15, 2026 | Alltoft Jennifer SadieDirector | Exercised options | 2,784 | - |
| August 15, 2026 | Capone Mark ChristopherDirector | Exercised options | 2,784 | - |
| August 13, 2026 | Tripeny R TonyDirector | Bought | 900 | $102.3K |
Who owns MLAB
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Conestoga Capital Advisors13G, passive with 1 related filers | 11.38% | January 10, 2025 |
| Long Path Smaller Companies Fund, LP13G, passive with 5 related filers | 8.6% | July 7, 2026 |
| BlackRock, Inc.13G, passive | 7.9% | October 27, 2026 |
| Wasatch Advisors LP13G, passive | 6.9% | October 9, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 159 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Long Path Partners LP | 477,126 | +71,543 |
| BlackRock, Inc. | 440,552 | +46,701 |
| Boston Partners | 265,149 | -3,562 |
| Vanguard Capital Management LLC | 237,457 | +4,814 |
| Aqr Capital Management LLC | 203,739 | +33,177 |
| Ranger Investment Management, L.P. | 173,988 | -28,915 |
| Morgan Stanley | 156,979 | -5,137 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | 155,771 | +469 |
| Raymond James Financial Inc | 149,937 | +27,026 |
| Dimensional Fund Advisors LP | 148,395 | +23,765 |
| Geode Capital Management, LLC | 139,682 | +11,680 |
| Kennedy Capital Management LLC | 138,301 | -4,042 |
| Jacobs Levy Equity Management, Inc | 130,838 | +86,421 |
| State Street Corp | 124,292 | +2,224 |
| Russell Investments Group, Ltd. | 121,845 | -13,224 |
| Wasatch Advisors LP | 115,668 | +64,435 |
| Royce & Associates LP | 113,395 | -47,834 |
| Crawford Investment Counsel Inc | 98,805 | +3,270 |
| Fmr LLC | 88,857 | +82,387 |
| D. E. Shaw & Co., Inc. | 81,755 | +27,197 |
Insiders
10 insiders reported holding 96,956 shares in total, about $12.4M at the last price.
| Holder | Shares |
|---|---|
| Sakys JohnCFO | 19,785 |
| Sullivan John JamesDirector | 19,418 |
| Ladiwala Shiraz ShabanaliDirector | 12,333 |
| Tripeny R TonyDirector | 9,082 |
| Alltoft Jennifer SadieDirector | 7,662 |
| Kadia SiddharthaPresident and CEO | 7,0937,093 held indirectly |
| Hall ShannonDirector | 6,973 |
| Archbold Brian DavidSVP Operations | 6,377 |
| Capone Mark ChristopherDirector | 6,213 |
| Crennen Lyndsey ElizabethCAO | 2,020 |
Questions about MLAB
What does Mesa Laboratories Inc do?
Mesa Laboratories Inc is a company in the Industrials sector, listed on NASDAQ as MLAB. Its shares trade on NASDAQ under the ticker MLAB.
What is Mesa Laboratories Inc's net worth?
Mesa Laboratories Inc has a market value (market cap) of $715.3M at the latest share price, and shareholders' equity of $194.6M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Mesa Laboratories Inc profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $6.7M on revenue of $251.3M, a net margin of 2.7%.
How much revenue does Mesa Laboratories Inc make?
Over the twelve months to September 30, 2026 Mesa Laboratories Inc reported revenue of $251.3M. That is 2.5% more than a year earlier.
When did Mesa Laboratories Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 9, 2026. It covers the period to September 30, 2026.
When is Mesa Laboratories Inc's next earnings report?
Mesa Laboratories Inc's next report is expected around February 2, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Mesa Laboratories Inc pay a dividend?
Yes. Mesa Laboratories Inc paid dividends of $0.64 per share in fiscal 2026, a yield of 0.50% at the current price.
Similar companies
Compare MLAB with
Follow MLAB
Get an email when Mesa Laboratories Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Mesa Laboratories Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.